<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39408041</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>19</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Impact of Inhaled Nitric Oxide (iNO) on the Outcome of COVID-19 Associated ARDS.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5981</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13195981</ELocationID><Abstract><AbstractText><b>Background:</b> Inhaled nitric oxide (iNO) can improve oxygenation in acute respiratory syndrome (ARDS), has anti-inflammatory and antithrombotic effects, and can inhibit coronavirus- replication. The study aim was to investigate the impact of iNO in COVID-19 associated ARDS (CARDS) on oxygenation, the length of mechanical ventilation (MV), the level of inflammatory markers and the rate of thrombotic events during ICU stay. <b>Methods:</b> This was a retrospective, observational, monocentric study analyzing the effect of INO (15 parts per million) vs. non-iNO in adult ventilated CARDS patients on oxygenation, the level of inflammatory markers, and the rate of thrombotic events during ICU stay. Within the iNO group, the impact on gas exchange was assessed by comparing arterial blood gas results obtained at different time points. <b>Results:</b> Overall, 19/56 patients were treated with iNO, with no difference regarding sex, age, body mass index, and SOFA-/APACHE II- score between the iNO and non-iNO groups. iNO improved oxygenation in iNO-responders (7/19) and had no impact on inflammatory markers or the rate of thrombotic events but was associated with an increased MV length. <b>Conclusions:</b> iNO was able to improve oxygenation in CARDS in iNO-responders but did not show an impact on inflammatory markers or the rate of thrombotic events, while it was associated with an increased MV length.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stoll</LastName><ForeName>Sandra Emily</ForeName><Initials>SE</Initials><Identifier Source="ORCID">0000-0002-4803-1362</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Böttiger</LastName><ForeName>Bernd W</ForeName><Initials>BW</Initials><Identifier Source="ORCID">0000-0001-8000-8931</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dusse</LastName><ForeName>Fabian</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-7762-6966</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leister</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-1932-0701</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leupold</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><Identifier Source="ORCID">0009-0006-6048-5419</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menzel</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Overbeek</LastName><ForeName>Remco</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-4046-0234</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathes</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0231-0681</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ARDS</Keyword><Keyword MajorTopicYN="N">COVID-19 associated ARDS</Keyword><Keyword MajorTopicYN="N">NO</Keyword><Keyword MajorTopicYN="N">iNO</Keyword><Keyword MajorTopicYN="N">inhaled nitric oxide</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39408041</ArticleId><ArticleId IdType="pmc">PMC11478273</ArticleId><ArticleId IdType="doi">10.3390/jcm13195981</ArticleId><ArticleId IdType="pii">jcm13195981</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nasrullah A., Virk S., Shah A., Jacobs M., Hamza A., Sheikh A.B., Javed A., Butt M.A., Sangli S. Acute Respiratory Distress Syndrome and the Use of Inhaled Pulmonary Vasodilators in the COVID-19 Era: A Narrative Review. Life. 2022;12:1766. doi: 10.3390/life12111766.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12111766</ArticleId><ArticleId IdType="pmc">PMC9695622</ArticleId><ArticleId IdType="pubmed">36362921</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattinoni L., Chiumello D., Rossi S. COVID-19 pneumonia: ARDS or not? Crit. Care. 2020;24:154. doi: 10.1186/s13054-020-02880-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02880-z</ArticleId><ArticleId IdType="pmc">PMC7160817</ArticleId><ArticleId IdType="pubmed">32299472</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaid Y., Guessous F., Puhm F., Elhamdani W., Chentoufi L., Morris A.C., Cheikh A., Jalali F., Boilard E., Flamand L. Platelet reactivity to thrombin differs between patients with COVID-19 and those with ARDS unrelated to COVID-19. Blood Adv. 2021;5:635–639. doi: 10.1182/bloodadvances.2020003513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2020003513</ArticleId><ArticleId IdType="pmc">PMC7846461</ArticleId><ArticleId IdType="pubmed">33560374</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersson J., Glenny R.W. Gas exchange and ventilation-perfusion relationships in the lung. Eur. Respir. J. 2014;44:1023–1041. doi: 10.1183/09031936.00037014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00037014</ArticleId><ArticleId IdType="pubmed">25063240</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan S.S., Capstick T., Ahmed R., Kow C.S., Mazhar F., Merchant H.A., Zaidi S.T.R. Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: A systematic review and meta-analysis. Expert Rev. Respir. Med. 2020;14:1149–1163. doi: 10.1080/17476348.2020.1804365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17476348.2020.1804365</ArticleId><ArticleId IdType="pmc">PMC7544968</ArticleId><ArticleId IdType="pubmed">32734777</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossaint R., Falke K.J., Lopez F., Slama K., Pison U., Zapol W.M. Inhaled nitric oxide for the adult respiratory distress syndrome. N. Engl. J. Med. 1993;328:399–405. doi: 10.1056/NEJM199302113280605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199302113280605</ArticleId><ArticleId IdType="pubmed">8357359</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebistorf F., Karam O., Wetterslev J., Afshari A. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults. Cochrane Database Syst. Rev. 2016;2016:CD002787. doi: 10.1002/14651858.CD002787.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD002787.pub3</ArticleId><ArticleId IdType="pmc">PMC6464789</ArticleId><ArticleId IdType="pubmed">27347773</ArticleId></ArticleIdList></Reference><Reference><Citation>Monsalve-Naharro J.A., Domingo-Chiva E., Garcia Castillo S., Cuesta-Montero P., Jimenez-Vizuete J.M. Inhaled nitric oxide in adult patients with acute respiratory distress syndrome. Farm. Hosp. 2017;41:292–312. doi: 10.7399/fh.2017.41.2.10533.</Citation><ArticleIdList><ArticleId IdType="doi">10.7399/fh.2017.41.2.10533</ArticleId><ArticleId IdType="pubmed">28236803</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Liu P., Gao H., Sun B., Chao D., Wang F., Zhu Y., Hedenstierna G., Wang C.G. Inhalation of nitric oxide in the treatment of severe acute respiratory syndrome: A rescue trial in Beijing. Clin. Infect. Dis. 2004;39:1531–1535. doi: 10.1086/425357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/425357</ArticleId><ArticleId IdType="pmc">PMC7107896</ArticleId><ArticleId IdType="pubmed">15546092</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins S.R., Johnson E.C., Richardson R.S., Wagner H., De Rosa M., Wagner P.D. Effects of inhaled nitric oxide on gas exchange in lungs with shunt or poorly ventilated areas. Am. J. Respir. Crit. Care Med. 1997;156:484–491. doi: 10.1164/ajrccm.156.2.9607114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.156.2.9607114</ArticleId><ArticleId IdType="pubmed">9279228</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano G.B., Esch T., Kream R.M. Potential Immunoregulatory and Antiviral/SARS-CoV-2 Activities of Nitric Oxide. Med. Sci. Monit. 2020;26:e925679. doi: 10.12659/MSM.925679.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.925679</ArticleId><ArticleId IdType="pmc">PMC7271680</ArticleId><ArticleId IdType="pubmed">32454510</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler H., Beland J.L., Del-Pan N.C., Kobzik L., Brewer J.P., Martin T.R., Rimm I.J. Suppression of herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2) J. Exp. Med. 1997;185:1533–1540. doi: 10.1084/jem.185.9.1533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.185.9.1533</ArticleId><ArticleId IdType="pmc">PMC2196291</ArticleId><ArticleId IdType="pubmed">9151890</ArticleId></ArticleIdList></Reference><Reference><Citation>Pope M., Marsden P.A., Cole E., Sloan S., Fung L.S., Ning Q., Ding J.W., Leibowitz J.L., Phillips M.J., Levy G.A. Resistance to murine hepatitis virus strain 3 is dependent on production of nitric oxide. J. Virol. 1998;72:7084–7090. doi: 10.1128/JVI.72.9.7084-7090.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.72.9.7084-7090.1998</ArticleId><ArticleId IdType="pmc">PMC109929</ArticleId><ArticleId IdType="pubmed">9696801</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane T.E., Paoletti A.D., Buchmeier M.J. Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus. J. Virol. 1997;71:2202–2210. doi: 10.1128/jvi.71.3.2202-2210.1997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.71.3.2202-2210.1997</ArticleId><ArticleId IdType="pmc">PMC191327</ArticleId><ArticleId IdType="pubmed">9032354</ArticleId></ArticleIdList></Reference><Reference><Citation>Rimmelzwaan G.F., Baars M.M., de Lijster P., Fouchier R.A., Osterhaus A.D. Inhibition of influenza virus replication by nitric oxide. J. Virol. 1999;73:8880–8883. doi: 10.1128/JVI.73.10.8880-8883.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.10.8880-8883.1999</ArticleId><ArticleId IdType="pmc">PMC112914</ArticleId><ArticleId IdType="pubmed">10482647</ArticleId></ArticleIdList></Reference><Reference><Citation>Karupiah G., Harris N. Inhibition of viral replication by nitric oxide and its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites. J. Exp. Med. 1995;181:2171–2179. doi: 10.1084/jem.181.6.2171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.181.6.2171</ArticleId><ArticleId IdType="pmc">PMC2192048</ArticleId><ArticleId IdType="pubmed">7539042</ArticleId></ArticleIdList></Reference><Reference><Citation>Akerstrom S., Mousavi-Jazi M., Klingstrom J., Leijon M., Lundkvist A., Mirazimi A. Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus. J. Virol. 2005;79:1966–1969. doi: 10.1128/JVI.79.3.1966-1969.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.3.1966-1969.2005</ArticleId><ArticleId IdType="pmc">PMC544093</ArticleId><ArticleId IdType="pubmed">15650225</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricciardolo F.L.M., Bertolini F., Carriero V., Hogman M. Nitric oxide’s physiologic effects and potential as a therapeutic agent against COVID-19. J. Breath Res. 2020;15:014001. doi: 10.1088/1752-7163/abc302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/1752-7163/abc302</ArticleId><ArticleId IdType="pubmed">33080582</ArticleId></ArticleIdList></Reference><Reference><Citation>Everett W., Scurr D.J., Rammou A., Darbyshire A., Hamilton G., de Mel A. A Material Conferring Hemocompatibility. Sci. Rep. 2016;6:26848. doi: 10.1038/srep26848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep26848</ArticleId><ArticleId IdType="pmc">PMC4893622</ArticleId><ArticleId IdType="pubmed">27264087</ArticleId></ArticleIdList></Reference><Reference><Citation>Thachil J. What do monitoring platelet counts in COVID-19 teach us? J. Thromb. Haemost. 2020;18:2071–2072. doi: 10.1111/jth.14879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14879</ArticleId><ArticleId IdType="pmc">PMC7267313</ArticleId><ArticleId IdType="pubmed">32344467</ArticleId></ArticleIdList></Reference><Reference><Citation>Toolsie O., Gomceli U., Diaz-Fuentes G. Inhaled Nitric Oxide as an Adjunct to Thrombolytic Therapy in a Patient with Submassive Pulmonary Embolism and Severe Hypoxemia. Case Rep. Crit. Care. 2019;2019:5184702. doi: 10.1155/2019/5184702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/5184702</ArticleId><ArticleId IdType="pmc">PMC6458947</ArticleId><ArticleId IdType="pubmed">31032122</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson N.D., Fan E., Camporota L., Antonelli M., Anzueto A., Beale R., Brochard L., Brower R., Esteban A., Gattinoni L., et al. The Berlin definition of ARDS: An expanded rationale, justification, and supplementary material. Intensive Care Med. 2012;38:1573–1582. doi: 10.1007/s00134-012-2682-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-012-2682-1</ArticleId><ArticleId IdType="pubmed">22926653</ArticleId></ArticleIdList></Reference><Reference><Citation>The Acute Respiratory Distress Syndrome Network. Brower R.G., Matthay M.A., Morris A., Schoenfeld D., Thompson B.T., Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N. Engl. J. Med. 2000;342:1301–1308. doi: 10.1056/NEJM200005043421801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200005043421801</ArticleId><ArticleId IdType="pubmed">10793162</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerin C., Reignier J., Richard J.C., Beuret P., Gacouin A., Boulain T., Mercier E., Badet M., Mercat A., Baudin O., et al. Prone positioning in severe acute respiratory distress syndrome. N. Engl. J. Med. 2013;368:2159–2168. doi: 10.1056/NEJMoa1214103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1214103</ArticleId><ArticleId IdType="pubmed">23688302</ArticleId></ArticleIdList></Reference><Reference><Citation>Group R.C., Horby P., Lim W.S., Emberson J.R., Mafham M., Bell J.L., Linsell L., Staplin N., Brightling C., Ustianowski A., et al. Dexamethasone in Hospitalized Patients with Covid-19. N. Engl. J. Med. 2021;384:693–704. doi: 10.1056/NEJMoa2021436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Germann P., Braschi A., Della Rocca G., Dinh-Xuan A.T., Falke K., Frostell C., Gustafsson L.E., Herve P., Jolliet P., Kaisers U., et al. Inhaled nitric oxide therapy in adults: European expert recommendations. Intensive Care Med. 2005;31:1029–1041. doi: 10.1007/s00134-005-2675-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-005-2675-4</ArticleId><ArticleId IdType="pubmed">15973521</ArticleId></ArticleIdList></Reference><Reference><Citation>Redaelli S., Pozzi M., Giani M., Magliocca A., Fumagalli R., Foti G., Berra L., Rezoagli E. Inhaled Nitric Oxide in Acute Respiratory Distress Syndrome Subsets: Rationale and Clinical Applications. J. Aerosol Med. Pulm. Drug Deliv. 2023;36:112–126. doi: 10.1089/jamp.2022.0058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jamp.2022.0058</ArticleId><ArticleId IdType="pmc">PMC10402704</ArticleId><ArticleId IdType="pubmed">37083488</ArticleId></ArticleIdList></Reference><Reference><Citation>Mekontso Dessap A., Papazian L., Schaller M., Nseir S., Megarbane B., Haudebourg L., Timsit J.F., Teboul J.L., Kuteifan K., Gainnier M., et al. Inhaled nitric oxide in patients with acute respiratory distress syndrome caused by COVID-19: Treatment modalities, clinical response, and outcomes. Ann. Intensive Care. 2023;13:57. doi: 10.1186/s13613-023-01150-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-023-01150-9</ArticleId><ArticleId IdType="pmc">PMC10299982</ArticleId><ArticleId IdType="pubmed">37368036</ArticleId></ArticleIdList></Reference><Reference><Citation>Prakash A., Kaur S., Kaur C., Prabha P.K., Bhatacharya A., Sarma P., Medhi B. Efficacy and safety of inhaled nitric oxide in the treatment of severe/critical COVID-19 patients: A systematic review. Indian. J. Pharmacol. 2021;53:236–243. doi: 10.4103/ijp.ijp_382_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijp.ijp_382_21</ArticleId><ArticleId IdType="pmc">PMC8262415</ArticleId><ArticleId IdType="pubmed">34169911</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Sulaiman K., Korayem G.B., Altebainawi A.F., Al Harbi S., Alissa A., Alharthi A., Kensara R., Alfahed A., Vishwakarma R., Al Haji H., et al. Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: A multicenter cohort study. Crit. Care. 2022;26:304. doi: 10.1186/s13054-022-04158-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-022-04158-y</ArticleId><ArticleId IdType="pmc">PMC9527729</ArticleId><ArticleId IdType="pubmed">36192801</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhazzani W., Moller M.H., Arabi Y.M., Loeb M., Gong M.N., Fan E., Oczkowski S., Levy M.M., Derde L., Dzierba A., et al. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) Crit. Care Med. 2020;48:e440–e469. doi: 10.1097/CCM.0000000000004363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004363</ArticleId><ArticleId IdType="pmc">PMC7176264</ArticleId><ArticleId IdType="pubmed">32224769</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajendran R., Chathambath A., Al-Sehemi A.G., Pannipara M., Unnikrishnan M.K., Aleya L., Raghavan R.P., Mathew B. Critical role of nitric oxide in impeding COVID-19 transmission and prevention: A promising possibility. Environ. Sci. Pollut. Res. Int. 2022;29:38657–38672. doi: 10.1007/s11356-022-19148-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11356-022-19148-4</ArticleId><ArticleId IdType="pmc">PMC8902850</ArticleId><ArticleId IdType="pubmed">35258738</ArticleId></ArticleIdList></Reference><Reference><Citation>Alqahtani J.S., Aldhahir A.M., Al Ghamdi S.S., AlBahrani S., AlDraiwiesh I.A., Alqarni A.A., Latief K., Raya R.P., Oyelade T. Inhaled Nitric Oxide for Clinical Management of COVID-19: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public. Health. 2022;19:12803. doi: 10.3390/ijerph191912803.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912803</ArticleId><ArticleId IdType="pmc">PMC9566710</ArticleId><ArticleId IdType="pubmed">36232100</ArticleId></ArticleIdList></Reference><Reference><Citation>Adusumilli N.C., Zhang D., Friedman J.M., Friedman A.J. Harnessing nitric oxide for preventing, limiting and treating the severe pulmonary consequences of COVID-19. Nitric Oxide. 2020;103:4–8. doi: 10.1016/j.niox.2020.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.niox.2020.07.003</ArticleId><ArticleId IdType="pmc">PMC7362842</ArticleId><ArticleId IdType="pubmed">32681986</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerlach H., Keh D., Semmerow A., Busch T., Lewandowski K., Pappert D.M., Rossaint R., Falke K.J. Dose-response characteristics during long-term inhalation of nitric oxide in patients with severe acute respiratory distress syndrome: A prospective, randomized, controlled study. Am. J. Respir. Crit. Care Med. 2003;167:1008–1015. doi: 10.1164/rccm.2108121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.2108121</ArticleId><ArticleId IdType="pubmed">12663340</ArticleId></ArticleIdList></Reference><Reference><Citation>Akaberi D., Krambrich J., Ling J., Luni C., Hedenstierna G., Jarhult J.D., Lennerstrand J., Lundkvist A. Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro. Redox Biol. 2020;37:101734. doi: 10.1016/j.redox.2020.101734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2020.101734</ArticleId><ArticleId IdType="pmc">PMC7505071</ArticleId><ArticleId IdType="pubmed">33007504</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava S., Garg I., Hembrom A.A., Kumar B. Assessment of nitric oxide (NO) potential to mitigate COVID-19 severity. Virusdisease. 2021;32:589–594. doi: 10.1007/s13337-021-00702-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13337-021-00702-6</ArticleId><ArticleId IdType="pmc">PMC8173103</ArticleId><ArticleId IdType="pubmed">34099981</ArticleId></ArticleIdList></Reference><Reference><Citation>Herranz L., da Silveira J.G., Trocado L.F.L., Alvaraes A.L., Fittipaldi J. Inhaled Nitric Oxide in Patients with Severe COVID-19 Infection at Intensive Care Unit—A Cross Sectional Study. J. Crit. Care Med. 2021;7:318–319. doi: 10.2478/jccm-2021-0033.</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/jccm-2021-0033</ArticleId><ArticleId IdType="pmc">PMC8647665</ArticleId><ArticleId IdType="pubmed">34934824</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>